Flexion Therapeutics Inc. | Mutual Funds
Mutual Funds that own Flexion Therapeutics Inc.
American Funds Small Cap World Fund
2,872,000
7.6%
0
0.17%
06/30/2018
SPDR S&P Biotech ETF
1,547,679
4.09%
3,981
0.61%
09/06/2018
Wells Fargo Advantage Discovery Fund
1,151,303
3.04%
0
0.82%
07/31/2018
Vanguard Total Stock Market Index Fund
829,002
2.19%
0
0%
07/31/2018
iShares Russell 2000 ETF
703,028
1.86%
-375
0.03%
09/06/2018
Dreyfus Opportunistic Small Cap Fund
634,044
1.68%
0
1.14%
04/30/2018
Dreyfus-Boston Company Small & Mid Cap Growth Fund
627,838
1.66%
0
0.76%
07/31/2018
Pictet - Biotech
561,161
1.48%
131,238
0.81%
03/31/2018
Wells Fargo Advantage Small Company Growth Portfolio
489,562
1.3%
0
0.46%
07/31/2018
Vanguard Extended Market Index Fund
465,942
1.23%
0
0.02%
07/31/2018
| Address |
10 Mall Road
Burlington Massachusetts 01803
United States
|
|
Employees
|
- |
| Website |
http://www.flexiontherapeutics.com |
| Updated |
07/08/2019 |
| Flexion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. The firm specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. |
